Company
Neos Therapeutics, Inc. (0001467652)
Standardized SEC financial data for Neos Therapeutics, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001467652 · Pharmaceutical Preparations.
Income statement
| USD | FY2016 | FY2017 | FY2018 | FY2019 |
|---|---|---|---|---|
| Revenue | $10.0M | $27.1M | $50.0M | $64.6M |
| Cost of revenue | $11.7M | $14.0M | $26.9M | $25.1M |
| Gross profit | -$1.7M | $13.1M | $23.1M | $39.5M |
| R&D expense | $12.2M | $9.0M | $8.5M | $8.6M |
| SG&A expense | $49.3M | $46.9M | $44.1M | $28.1M |
| Operating income | -$75.8M | -$56.5M | -$43.5M | -$10.4M |
| EBITDA | -$74.2M | -$55.2M | -$41.7M | — |
| Interest expense | $6.9M | $10.1M | $9.0M | $8.0M |
| Pretax income | — | -$65.8M | -$51.7M | -$16.9M |
| Income tax | — | — | — | $11K |
| Net income | -$83.3M | -$65.8M | -$51.7M | -$16.9M |
Standardized from Neos Therapeutics, Inc.'s SEC filings — per-share figures split-adjusted. Full history via the API.
Balance sheet
| USD | FY2016 | FY2017 | FY2018 | FY2019 |
|---|---|---|---|---|
| Cash & equivalents | $39.8M | $50.4M | $46.5M | $24.9M |
| Inventory | $6.5M | $12.1M | $10.8M | $11.7M |
Cash flow
| USD | FY2016 | FY2017 | FY2018 | FY2019 |
|---|---|---|---|---|
| Operating cash flow | -$70.6M | -$53.3M | -$41.4M | -$10.8M |
| Capital expenditures | $3.5M | $2.5M | $1.4M | $1.1M |
Get 0001467652 data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001467652/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001467652/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"